Algernon Pharmaceuticals

/Algernon Pharmaceuticals

Follow-on

Algernon Pharmaceuticals

Pharmaceutical

Algernon Pharmaceuticals Inc. ("Algernon" or the "Company") is a clinical stage drug re-purposing company that investigates already approved drugs, and naturally occurring compounds, for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals.

Symbol

AGNP

Last Closing Price
$4.35

Shares
2,133,004

Anticipated Date
June 10, 2022

Underwriters
LADENBURG, THALMANN & CO., INC.

This offering is no longer available

To view the prospectus for Algernon Pharmaceuticals, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange